Sanket Koul
Sanket Koul
Economic survey says India could attain WHO doctor availability norms of 1:1000 by 2030
It is expected that representatives for MSMEs pharma manufacturers may raise the issue of extension of Revised Schedule M implementation timelines
This comes even as the country has increased girls' toilet coverage in rural schools from 66.4 per cent in 2018 to 72 per cent in 2024
Hospital chain to set up 500 bed hospital in Thane on built-to-suit basis, focus on brownfield expansion
Haryana IMA calls it inadequate as unpaid dues since October amount to Rs 400 cr
Buyers now more involved in ultra-luxury housing, says DLF Home Developers Joint MD
Sources says institute is working on recruiting new staff, trying to open back soon
DLF's revenue from operations grew marginally by 0.5 per cent to Rs 1,528.7 crore in Q3FY25, compared to Rs 1,521.2 crore in Q3FY24
This was in violation of the UCPMP rules, which regulate interactions between pharmaceutical companies and HCPs and prohibit foreign trips, gifts, and inducements as unethical marketing practices
Most drugs found NSQ by central labs this month were produced in units located in cities such as Ahmedabad, Vadodara, Himachal Pradesh's Baddi, Puducherry, Roorkee and Haridwar
Mankind's revenue from operations rose to Rs 3,230 crore in Q3FY25, a 24 per cent Y-o-Y rise from Rs 2,607 crore reported in Q3FY24
The growth was largely driven by revenue from its recently acquired nicotine replacement therapy (NRT) portfolio and performance in the European and emerging markets
Govt says India on track to meet SDG health targets well before 2030 deadline
The medtech industry is also looking for an opening in stroke care, with experts suggesting collaborations such as public-private partnerships (PPP)
This follows US President Donald Trump's signing of an executive order on Monday, announcing the country's withdrawal from the WHO
Domestic manufacturers added that the order will also stop the unregulated influx of second hand medical devices which could have been detrimental to the patient safety in India
Health Ministry to constitute expert committee, import suspended until policy framework is finalised
The scheme aims to refund to exporters the embedded central, state, and local duties and taxes paid on inputs that were so far not refunded or rebated
The Centre's flagship health scheme will run in convergence with the state's Gopabandhu Jan Arogya Yojana (GJAY)
Pharma groups had wanted two year extension, will raise concerns with govt